Natus Medical Sets New 12-Month High at $29.90 (BABY)
Natus Medical (NASDAQ:BABY) shares hit a new 52-week high during trading on Wednesday , Analyst Ratings News reports. The company traded as high as $29.90 and last traded at $28.82, with a volume of 101,818 shares trading hands. The stock had previously closed at $29.06.
The stock has a 50-day moving average of $27.44 and a 200-day moving average of $25.70. The company has a market cap of $902.8 million and a price-to-earnings ratio of 31.38.
Natus Medical (NASDAQ:BABY) last posted its quarterly earnings results on Wednesday, July 23rd. The company reported $0.28 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.26 by $0.02. The company had revenue of $86.30 million for the quarter, compared to the consensus estimate of $84.85 million. During the same quarter in the prior year, the company posted $0.21 earnings per share. The company’s quarterly revenue was up 4.9% on a year-over-year basis. Analysts expect that Natus Medical will post $1.22 EPS for the current fiscal year.
Natus Medical Incorporated (NASDAQ:BABY) is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders.
Receive News & Ratings for Natus Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.